Crisà, E., Mora, E., Germing, U., Bally, C., Diez Campelo, M., Myllymäki, M., . . . Santini, V. (2024). Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm. Leukemia, 38(10), 2259. https://doi.org/10.1038/s41375-024-02360-1
Chicago-referens (17:e uppl.)Crisà, Elena, et al. "Transfusion Independence After Lenalidomide Discontinuation in Patients with Del(5q) Myelodysplastic Neoplasm." Leukemia 38, no. 10 (2024): 2259. https://doi.org/10.1038/s41375-024-02360-1.
MLA-referens (9:e uppl.)Crisà, Elena, et al. "Transfusion Independence After Lenalidomide Discontinuation in Patients with Del(5q) Myelodysplastic Neoplasm." Leukemia, vol. 38, no. 10, 2024, p. 2259, https://doi.org/10.1038/s41375-024-02360-1.